Výsledky vyhledávání

High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma

Autor: A C Mehta, Michael W. Beaty, T C Gentile, K W Zamkoff, R E Hutchison, M D Matulis

Publikováno v: Bone marrow transplantation. 33(6)

Primary systemic anaplastic lymphoma kinase (ALK)-negative anaplastic large-cell lymphoma (ALCL) has a poor prognosis. This study sought to determine if high-dose therapy and ASCT results in long-term disease-free survival (DFS) in patients with recu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4808956c02365c44c3b95e23b00e96
https://pubmed.ncbi.nlm.nih.gov/15004538

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání